They developed an anti-disialoganglioside GD2 specific antibody-LTα fusion protein, and demonstrated that this fusion protein was able to favor subcutaneous tumor and established pulmonary metastasis eradication, and to prolong survival. The gene discussed is LTA; the disease is neoplasm.